Taken together, these data show that GVAX vaccination induces a detectable, but relatively blunted CD8 T cell response in prostate tumor-bearing mice, and this blunted response correlates with CTLA-4 expression on specific T cells, especially in the target organ. The gene discussed is CTLA4; the disease is prostate neoplasm.